Argent BioPharma Limited
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Argent BioPharma Limited's balance sheet done over the years? Its assets were worth $10,787,379 last year, which is less than in the previous period. 154% of Argent BioPharma Limited’s total assets is currently financed by debt. Its liabilities reached the amount of $16,612,199, which means an increase by 306% compared compared to last year.

Debt to Assets

Argent BioPharma Limited (LSE:RGT.L): Debt to assets
2015 1233579 290.60K 23.56%
2016 9167915 2.59M 28.31%
2018 11212161 4.09M 36.53%
2024 10787379 16.61M 154%

RGT.L Balance Sheet (2014 – 2023)

2023 2017 2015 2014
Assets
Current assets:
Cash and cash equivalents
702.87K5.52M4.42M213.85K
Short term investments
0000
Net receivables
476.53K39.51K10
Inventory
875.12K399.45K87.99K0
Other current assets
685.71K483.31K547.67K40.92K
Total current assets
2.74M6.45M5.05M254.78K
Non-current assets:
Property, Plant and Equipment
6.72M748.35K118.27K978.79K
Goodwill
0000
Intangible assets
03.97M3.96M0
Long term investments
1.32M40.85K00
Other non-current assets
0220.26K0
Total non-current assets
8.04M4.76M4.10M978.79K
Total assets
10.78M11.21M9.16M1.23M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
553.60K000
Short term debt
223.81K0602.51K0
Total current liabilities
12.17M4.05M2.58M195.16K
Non-current liabilities:
Long term debt
820.91K12.08K11.42K95.43K
Deferred tax
0000
Other non-current liabilities
16.75K28.57K12
Total non-current liabilities
4.43M40.66K11.42K95.43K
Total liabilities
16.61M4.09M2.59M290.60K
Data sourceData sourceData sourceData source